Best Telehealth for Wegovy HD: Who Actually Has It, What You'll Really Pay, and Who Can Start Now

By Weight Loss Provider GuideLast verified: Next check: May 22, 2026
Advertising disclosure: We earn affiliate commissions from some links on this page. This does not affect our rankings or what we write — providers don't pay for placement. Full disclosure →

The short answer

The best telehealth for Wegovy HD depends on one thing: whether you want the lowest cost, the most clinical support, or the quickest mainstream-brand experience. Here are the three paths that end the search for most eligible adults:

Lowest verified cash price

WeightWatchers Clinic (WW Med+) at $249/month for HD medication with a 12-month Medication Commitment ($2,988 charged upfront), plus $74/month WW Med+ membership (after a $25/month intro for first two months). Effective all-in cost over 12 months: about $314.83/month. Actual month-1 cash outlay: $3,013.

Most comprehensive telehealth program

Ro Body — start for $39, then $149/month ongoing (as low as $74/month when you prepay an annual plan). NovoCare-matched pricing ($399/month for HD), dedicated insurance concierge, and a free GLP-1 Insurance Coverage Checker.

Mainstream consumer-brand path with explicit HD pricing

Hims (men) or Hers (women). Both publicly list a dose range of 0.25 mg to 7.2 mg on their Wegovy pen pages. Membership is $39 first month, $149/month ongoing; medication billed separately.

Cleanest direct-to-door benchmark: If you already have an HD prescription from your own doctor, NovoCare Pharmacy ships HD at $399/month with no membership. Same for GoodRx Care Direct, which publishes HD at $399/month with a $39/month care fee.

Two things almost every competing page omits — read these before you click anywhere:

  1. You cannot start on Wegovy HD. The FDA label requires at least 4 weeks on the standard 2.4 mg dose first. No telehealth platform can prescribe HD as a first dose. If you're not on 2.4 mg yet, this isn't the right page for you today.
  2. Wegovy HD insurance coverage is in flux. Novo Nordisk's own live coverage checker currently states no insurance coverage is available for Wegovy injection 7.2 mg. Commercial formularies haven't added it yet. Plan to pay cash for HD right now, and re-check coverage every few months as formularies update.

What we actually verified

We're Weight Loss Provider Guide — an independent comparison resource for GLP-1 telehealth providers. Before ranking anything on this page, we pulled the receipts directly. Here's the audit so you can check us:

Manufacturer / clinical facts (confirmed via primary sources):

  • FDA approval date for Wegovy HD: March 19, 2026, under the Commissioner's National Priority Voucher (CNPV) pilot program — a 54-day review.
  • U.S. launch: April 2026, single-dose prefilled pens, 4 pens per carton = one month of treatment.
  • NovoCare self-pay benchmark: $399/month. Confirmed at novocare.com/pharmacy.html and wegovy.com.
  • Eligibility rule: Dose may be increased to 7.2 mg once weekly only after tolerating 2.4 mg for at least 4 weeks (per the FDA-approved prescribing information).
  • Savings Offer: The Wegovy Savings Offer terms include HD in the commercial-coverage branch at as little as $25/month. Government beneficiaries are excluded.
  • Current HD coverage status: Novo Nordisk's live coverage tool states no insurance coverage is currently available for the 7.2 mg dose.
  • Clinical efficacy: Average 20.7% body weight loss over 72 weeks in the STEP UP trial; about 1 in 3 lost 25% or more.
  • HD-specific side effect signal: About 22% of trial participants on 7.2 mg reported dysesthesia (tingling, burning, or altered skin sensations) vs. 6% on 2.4 mg and 0.3% on placebo.

Providers with explicit, on-page mention of Wegovy HD 7.2 mg (confirmed April 22, 2026):

  • WeightWatchers Med+Publishes HD-specific pricing including the 12-month Medication Commitment offer at $249/month.
  • HimsPublishes a pen dose range of 0.25 mg to 7.2 mg.
  • HersPublishes the same pen dose range.
  • NovoCare PharmacyThe source of truth ($399/month self-pay).
  • GoodRx Care DirectExplicit $399/month HD announcement.
Providers that dispense authentic Wegovy HD via NovoCare integration or Novo partnership but do not yet prominently feature HD-specific pricing: Ro Body (NovoCare Pharmacy integration for all Wegovy doses — confirm HD pricing at your eligibility visit), LifeMD (direct Novo Nordisk partnership — confirm HD availability at your visit), Sesame Care (routes to NovoCare Pharmacy for Wegovy self-pay — confirm HD availability at your visit).

Providers excluded from rankings:

  • Walgreens — their public Wegovy FAQ still referenced 2.4 mg as the injectable ceiling. That's stale for an HD-specific search.
  • Compounded semaglutide platforms — Wegovy HD is an FDA-approved brand medication. A compounded 7.2 mg semaglutide product is not Wegovy HD regardless of how it's marketed. The FDA has explicitly warned telehealth companies about implying compounded products are equivalent.

Quick eligibility check before you scroll further

Where you stand right now determines whether this page even applies to you:

Your current GLP-1 situationWhat this page says to do
Not on any Wegovy or GLP-1 yetStart at 0.25 mg first. HD is not a starting dose — you'll titrate up over several months before HD is an option.
On Wegovy 0.25 mg, 0.5 mg, 1 mg, or 1.7 mgKeep titrating. Your prescriber will likely move you to 2.4 mg next. HD comes after that, if needed.
On Wegovy 2.4 mg for less than 4 weeksFinish your 4 weeks at 2.4 mg first. Come back then.
On Wegovy 2.4 mg for 4+ weeks and tolerating it✅ You likely qualify for HD. Keep reading.
On Ozempic, Mounjaro, Rybelsus, or compounded semaglutideYou'll need to switch to branded Wegovy and titrate to 2.4 mg before HD is an option. Plan for 8–12 weeks for a transition.
On Zepbound (tirzepatide)See our Wegovy HD vs Zepbound breakdown below — it's a real decision, not a simple upgrade.

If the green check applies to you, you're ready to choose a route. Most of the heavy lifting on this page is for readers who are on 2.4 mg, tolerating it, and ready to step up.

Which Wegovy HD route fits you best — quick decision guide comparing telehealth support, flexibility, own prescriber, and mainstream app-style experience for 7.2 mg semaglutide
Decision guide: which Wegovy HD telehealth route fits your situation best. .

What is Wegovy HD (and why it's different from standard Wegovy)

Wegovy HD is a 7.2 mg weekly injection of semaglutide — the highest-dose semaglutide injection available anywhere. The FDA approved it on March 19, 2026. In the 72-week STEP UP trial, adults who stayed on 7.2 mg lost an average of 20.7% of their body weight, and about 1 in 3 lost 25% or more.

What's the same as standard Wegovy

  • Active ingredient (semaglutide)
  • Delivery method (subcutaneous injection)
  • Dose frequency (once weekly)
  • Boxed warning (thyroid C-cell tumor risk)
  • Mechanism (GLP-1 receptor agonist)

What's different

  • Dose ceiling: 7.2 mg (tripling the 2.4 mg ceiling)
  • Single-dose prefilled pen (4 per carton)
  • ~5 more percentage points of weight loss vs 2.4 mg
  • 22% dysesthesia signal (vs 6% at 2.4 mg)
  • Eligibility gate: must tolerate 2.4 mg ≥4 weeks

What Wegovy HD is not:

It is not a new drug, not a faster drug, not a replacement for standard Wegovy, and not the same as compounded semaglutide dosed at 7.2 mg. Only Novo Nordisk makes Wegovy HD. Only authentic Wegovy HD is FDA-approved. If a site offers "Wegovy HD" without a prescription or at prices dramatically below $399/month, that is not Wegovy HD.

Who qualifies for Wegovy HD through telehealth (the 4-week rule almost no one mentions)

To get a Wegovy HD prescription through any U.S. telehealth platform, you must meet Wegovy's underlying eligibility plus the HD-specific escalation rule.

Baseline Wegovy eligibility

  • • BMI of 30 or higher, or
  • • BMI of 27+ with at least one weight-related condition (high blood pressure, T2D, high cholesterol, sleep apnea, PCOS, or cardiovascular disease)

HD-specific prerequisite

  • • Already taking branded Wegovy 2.4 mg
  • • Tolerated it for at least 4 consecutive weeks
  • • Clinician judges additional weight reduction is clinically indicated

Automatic disqualifiers

  • • Personal/family history of medullary thyroid carcinoma (MTC)
  • • Multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • • Known hypersensitivity to semaglutide
  • • Pregnancy / breastfeeding
  • • Under 18 years old
A practical note on compounded semaglutide history: compounded semaglutide is not Wegovy, and a Wegovy HD prescriber may not consider time at a compounded 2.4 mg dose equivalent to branded Wegovy 2.4 mg for escalation purposes. Whether a specific clinician counts it is a case-by-case clinical judgment — raise it during your first visit.
Can you get Wegovy HD online? Step-by-step visual flowchart: already on Wegovy 2.4 mg, tolerated 4 weeks, telehealth clinician reviews history, qualify for authentic Wegovy HD 7.2 mg weekly injection
Step-by-step: how to get authentic Wegovy HD 7.2 mg online through telehealth. .

Best telehealth for Wegovy HD: the 7 access routes, side by side

Seven legitimate U.S. routes currently provide access to authentic Wegovy HD 7.2 mg. Below is the full access matrix — the single most useful piece of information on this page.

ProviderHD listed publicly?Medication (HD self-pay)Program feeEffective monthlyInsurance help
NovoCare Pharmacy (direct)✅ Yes — $399/mo explicitly$399/mo$0 (need your own prescriber)$399/moManufacturer Savings Offer only
GoodRx Care Direct✅ Yes — $399/mo announced$399/mo$39/mo care fee$438/moLight — nationwide pharmacy access
WeightWatchers Clinic (WW Med+)✅ Yes — explicit 7.2 mg pricing$249/mo on 12-month commitment ($2,988 upfront) or $399/mo standard$74/mo ongoing ($25/mo intro first 2 months)$314.83/mo effective over 12 months (with commitment) ← LOWESTCare team works with insurance
Hims✅ Yes — pen dose range 0.25–7.2 mgConfirm HD price at eligibility visit$39 first month; $149/mo ongoingConfirm at signupCash-pay model
Hers✅ Yes — pen dose range 0.25–7.2 mgSame as HimsSame as HimsConfirm at signupCash-pay model
Ro BodyNovoCare integration — confirm HD at signupNovoCare-matched (~$399/mo)$39 first month; $149/mo ongoing (as low as $74/mo with annual prepay)$473/mo annual / $548/mo monthlyInsurance concierge + free Coverage Checker (strongest verified)
LifeMDNovo partnership — confirm HD at visit$399/mo via NovoCare self-payProgram fee: confirm current rate (~$75–$149/mo)Confirm at signupIn-house prior-auth support
Sesame Care (Success by Sesame)Routes to NovoCare — confirm HD at visitNovoCare self-pay ($399/mo)$59/mo on annual plan$458/moProvider can assist with PA
All medication prices are self-pay (cash). Commercial insurance coverage for Wegovy HD is currently limited because most plans haven't yet added the 7.2 mg dose to their formularies. See the insurance section below. Once plans do add HD, the Wegovy Savings Offer can bring eligible commercially insured patients to as low as $25/month.

If you're in this situation, pick this provider

Find yourself below and go directly to the match. Each persona maps to the provider that genuinely serves it best.

If…

Your top priority is the lowest verified monthly cost for HD and you can prepay 12 months

WeightWatchers Clinic (WW Med+) with the 12-month Medication Commitment

$249/mo medication (prepaid $2,988 upfront) + $74/mo membership = $314.83/mo effective over 12 months.

See WW Med+ 12-month commitment →

If…

You want the most comprehensive FDA-approved Wegovy telehealth program with insurance navigation

Ro Body

Ro pairs 24/7 provider access with NovoCare Pharmacy integration and the strongest insurance concierge we verified.

Check Wegovy HD eligibility on Ro →

If…

You want a mainstream consumer-brand experience with explicit 7.2 mg dose listing

Hims (men) or Hers (women)

Both publicly list pen dose ranges up to 7.2 mg and separate medication from membership so the medication portion is HSA/FSA-eligible.

If…

You want the most clinical infrastructure — metabolic testing, lab work, and a refund guarantee

LifeMD

Direct Novo Nordisk partnership. Conditional refund guarantee on the program subscription fee (not the medication) if you don't reach 10% weight loss in a year — eligibility and participation requirements apply.

Check LifeMD Weight Management eligibility →

If…

You want to pick your own doctor and get same-day pharmacy pickup

Sesame Care (Success by Sesame)

$59/mo annual subscription, provider marketplace with ratings, same-day prescriptions routed to your local pharmacy.

See Success by Sesame →

If…

You already have a Wegovy HD prescription from your own doctor

NovoCare Pharmacy direct

$399/mo, no membership, shipped to your door. The cleanest benchmark on this page.

If…

You want nationwide pharmacy flexibility with a light connected-care layer

GoodRx Care Direct

$39/mo care + $399/mo medication = $438/mo all-in. Works at any participating pharmacy.

Check GoodRx Care Direct →

If you're not yet on 2.4 mg Wegovy

You can't start on HD. See our best telehealth for standard Wegovy guide to begin titration. Come back in a few months.

Ro Body review: the most comprehensive FDA-approved Wegovy program

Ro Body is the strongest choice for readers who want the full FDA-approved Wegovy telehealth experience — provider access, insurance navigation, and NovoCare-matched medication pricing — in a single program. Ro Body membership: $39 for the first month, $149/month ongoing, as low as $74/month when you prepay an annual plan.

Here's how Ro actually works:

  1. Complete an online intake (height, weight, medical history, current GLP-1 dose history — critical for HD eligibility).
  2. A licensed healthcare provider reviews your case and determines eligibility.
  3. If approved and paying cash, your prescription routes to NovoCare Pharmacy and ships to your door.
  4. If approved with insurance, Ro's insurance concierge works your prior authorization.
  5. You get unlimited 24/7 messaging, weight tracking, dose logging, lab orders, side-effect monitoring, and monthly check-ins.

Where Ro is genuinely strongest

  • Insurance concierge + free GLP-1 Coverage Checker
  • 24/7 messaging and comprehensive clinical program
  • Month-to-month or annual prepay — no upfront commitment
  • NovoCare-matched pricing for all Wegovy doses

Who should skip Ro

  • Cheapest 12-month cash price only → WeightWatchers with Medication Commitment
  • Want nationwide pharmacy pickup → GoodRx or Sesame
  • Have your own PCP who can write HD → NovoCare direct

Ro's GLP-1 Insurance Coverage Checker runs your plan before you pay anything.

WeightWatchers Clinic (WW Med+) review: the lowest verified HD price if you commit

WeightWatchers Med+ is the only telehealth provider we verified publishing explicit HD 7.2 mg pricing with a 12-month Medication Commitment that genuinely undercuts every other route. Standard HD pricing through WW is $399/month (same as NovoCare). But with their Medication Commitment — you prepay $2,988 upfront for 12 months of HD — you lock in $249/month medication for the year. Add $74/month WW Med+ membership (after a $25/month intro for your first two months), and your effective all-in cost over 12 months is about $314.83/month.

The real cash numbers, so nothing is hidden:

Month 1 (actual cash outlay at signup)$3,013 ($2,988 medication prepay + $25 first membership month)
Month 2$25 membership (medication already prepaid)
Months 3–12$74/month membership × 10 = $740 (medication already prepaid)
Total 12-month cost$3,778
Effective monthly$314.83 (lowest on this page)

Trade-offs you need to understand before prepaying $3,013:

  • Refund math is unkind if you cancel mid-year. You can cancel the Medication Commitment at any time, but only medication that hasn't yet shipped is refundable — and any refund calculates at the standard $399/month price, not the discounted $249.
  • 12 months is a real commitment at the highest available dose. If you haven't confirmed you tolerate semaglutide at HD, start on month-to-month at Ro or NovoCare first.
  • Promotional windows expire. At time of verification, the WW intro membership price runs through April 30, 2026, and the 12-month Medication Commitment offer runs through December 31, 2026. Check current deadlines at signup.

WW Med+ is perfect for:

Someone on Wegovy 2.4 mg for months, knows they tolerate semaglutide well, has ~$3,000 available upfront, and wants the lowest monthly cost on a brand-name HD route.

Skip WW Med+ if:

You're just stepping up to HD this month and haven't confirmed tolerance; you don't have $3,000 upfront; or you prioritize flexibility over lowest price.

Check current promo deadlines and full refund terms on the WW site before prepaying.

LifeMD review: the clinical depth play with a conditional refund guarantee

LifeMD is a strong fit if you want genuine clinical infrastructure around your Wegovy prescription — metabolic testing, lab work, and a conditional refund guarantee on the subscription fee. LifeMD has a direct partnership with Novo Nordisk and publishes Wegovy pen and pill on its consumer pages. Confirm HD-specific availability and current pricing during your eligibility visit.

LifeMD offers a conditional money-back guarantee: if you don't achieve at least 10% weight loss after one year on the program, LifeMD refunds your subscription fees. The guarantee has participation and eligibility requirements (program adherence, lab completion, and others), and it applies to the program fee — not the medication. Read LifeMD's full refund terms before relying on the guarantee.

  1. Complete an intake questionnaire about your health history and weight goals.
  2. Matched with a LifeMD provider who reviews your assessment, orders lab work including metabolic testing, and determines HD eligibility.
  3. If approved, prescription routes through LifeMD's pharmacy partners.
  4. LifeMD provides ongoing clinical support, medication adjustments, 24/7 async messaging, and same-day video availability.
  5. In-house prior-authorization support fights for coverage on your 2.4 mg dose and will be ready for HD once formularies add it.

LifeMD is perfect for:

Someone who wants to feel genuinely under medical supervision, wants metabolic testing, or wants the conditional refund safety net at the 1-year mark.

The honest trade-off:

LifeMD's intake and matching can take about a week vs Ro's typical 2-day turnaround. That extra week buys you real labs and a documented metabolic baseline.

Includes metabolic testing and insurance prior-authorization support.

Hims and Hers review: the app-based cash-pay HD route

Hims and Hers both publicly list Wegovy pen dose ranges spanning 0.25 mg through 7.2 mg, making them two of only five platforms where we confirmed explicit HD dose support on the consumer-facing product page. Hims is the male-coded brand, Hers is the female-coded brand — clinical care is equivalent, positioning differs.

What's publicly verified (April 22, 2026)Detail
Dose range publicly listed0.25 mg to 7.2 mg (HD included)
Membership$39 first month, $149/month ongoing
Pen pricing entry pointStarts at $199/month for lower doses (promotional)
Billing structureMedication billed separately from membership
State availabilityGLP-1 access not yet available in all 50 states
HD-specific medication priceConfirm at eligibility visit — expect NovoCare benchmark (~$399/month)

What Hims and Hers do better than anyone:

  • • Consumer-brand experience and app polish
  • • 24/7 care team access with fast response times
  • • Peer community access during titration
  • • HSA/FSA-friendly separation of medication and membership

What they do less well:

  • • No insurance-first path (Ro or LifeMD is better for PA)
  • • GLP-1 access not in all 50 states — check before committing
  • • Higher total monthly cost than WW with commitment

Sesame Care review: the flexibility and provider-choice play

Sesame Care's Success by Sesame program is the most flexible route for readers who want to pick their own doctor, get same-day pharmacy pickup, or minimize the telehealth subscription fee. Sesame's $59/month program fee (on an annual plan) is the lowest telehealth subscription on this page. Medication for Wegovy self-pay is routed through NovoCare Pharmacy at NovoCare's $399/month price. Confirm HD-specific availability during your first visit.

Provider choice: You pick your clinician from a marketplace with reviews and ratings rather than being randomly assigned.
Same-day prescriptions: If your chosen provider agrees, your prescription can hit your local pharmacy within hours of the video visit.
Transparent prescribing: Sesame isn't a pharmacy, so they don't have a financial incentive to push you toward one medication over another.
Promotional offers: Sesame has publicly partnered with Costco on discounted Wegovy and Ozempic pricing for Costco members; confirm today's offer at signup.

Sesame is perfect for:

Costco members, readers who want same-day pharmacy pickup, readers who prefer picking their own doctor, and readers where the low monthly subscription ($59 vs $149) materially changes the math.

Skip Sesame if:

You want a heavy insurance-navigation stack (Ro is stronger), want a money-back guarantee (LifeMD), or are chasing the absolute lowest all-in price (WW with commitment).

NovoCare Pharmacy and GoodRx: the clean benchmark routes

If you already have a Wegovy HD prescription from your own doctor, the cheapest honest path is NovoCare Pharmacy direct at $399/month with no telehealth membership fee on top. It's the manufacturer's own pharmacy, shipping direct to your door, no subscription, no care fee, no platform markup. If you want connected care at any U.S. pharmacy instead of mail order, GoodRx Care Direct charges a $39/month care fee plus the same $399/month for HD — $438/month all-in.

When to choose NovoCare direct:

  • • Your PCP or endocrinologist can write the HD prescription
  • • You don't want subscription friction or monthly check-ins
  • • You've been on Wegovy long enough that ongoing telehealth oversight isn't adding value
  • • You want home delivery without a program layer

When to choose GoodRx Care Direct:

  • • You need a prescription but don't want a heavyweight telehealth membership
  • • You want nationwide pharmacy access for refills
  • • $39/month care is an acceptable trade for keeping a provider on hand
Why these aren't the right fit for most HD searchers: NovoCare alone does none of the clinical work — it's a fulfillment pharmacy, not a care team. GoodRx sits lean in between. For most readers, the extra $30–$80/month at Ro, LifeMD, or WW buys real clinical support.

Walgreens and why we don't recommend it for Wegovy HD

Walgreens Weight Management publicly lists Wegovy at $149+/month with a $49 visit fee, but at verification their consumer FAQ still referenced 2.4 mg as the injectable ceiling — a stale signal on a page about the 7.2 mg HD formulation. If Walgreens' public information hasn't caught up with the March 2026 HD approval and April 2026 launch, that's a red flag for a reader looking for a verified HD route today.

Walgreens may well dispense HD — they're a major retail pharmacy. But their telehealth front end is not currently positioned around HD, which means clinician familiarity with the HD-specific eligibility gate isn't guaranteed, HD-specific pricing clarity is missing, and HD stocking in your local store isn't assured. If you want a no-subscription route, NovoCare Pharmacy direct is a cleaner answer.

What Wegovy HD really costs: the 12-month total cost of ownership

The real price spread comes from the platform fees on top of the $399/month medication — ranging from $0 (NovoCare direct) to $149/month (Ro, Hims, Hers monthly billing). The one material deviation from the $399 benchmark is WeightWatchers' 12-month Medication Commitment, which drops medication to $249/month in exchange for $2,988 upfront.

12-month Wegovy HD cost, all-in. Verified .
ScenarioMedication (12 mo)Program fee (12 mo)Total 12-monthEffective monthly
NovoCare Pharmacy direct (own prescriber)$4,788$0$4,788$399/mo
GoodRx Care Direct$4,788$468 ($39 × 12)$5,256$438/mo
WeightWatchers Med+ with 12-month Medication Commitment$2,988 (prepaid)$790 ($25 × 2 + $74 × 10)$3,778$314.83/mo ← LOWEST
Ro Body on annual prepay plan$4,788$888 ($74 × 12)$5,676$473/mo
Ro Body on monthly billing$4,788$1,678 ($39 + $149 × 11)$6,466$538.83/mo
Hims or Hers on monthly billing$4,788$1,678 ($39 + $149 × 11)$6,466$538.83/mo
Sesame Care (annual plan)$4,788$708 ($59 × 12)$5,496$458/mo
LifeMD$4,788Program fee varies (~$75–$149/mo) — confirm at signup~$5,688–$6,576~$474–$548/mo
Month-1 cash outlay is a separate question worth checking. For every scenario above except WW with commitment, month-1 cash outlay is approximately the first medication cost plus the intro membership fee. For WW with commitment, month-1 cash outlay is $3,013 ($2,988 prepaid medication + $25 first membership month).

The practical takeaway:

  • Best absolute price if you can prepay 12 months: WeightWatchers with Medication Commitment ($314.83/mo effective)
  • Best price on month-to-month flexibility: NovoCare direct ($399/mo — but you need your own prescriber)
  • Best value for clinical infrastructure: LifeMD or Ro — pay more for the full-stack program
  • Best value for mainstream-brand simplicity: Hims or Hers

Every number above was verified April 22, 2026. Confirm the number on a provider's site on the day you sign up.

Wegovy HD with insurance: the honest reality right now

Novo Nordisk's own live coverage tool at novocare.com currently states no insurance coverage is available for Wegovy injection 7.2 mg. That's normal for a medication launched weeks ago — commercial plans update their formularies on their own cycles, often quarterly or at plan-year renewals. The practical result: for most patients in April 2026, Wegovy HD is a cash-pay medication.

Commercial insurance isn't likely to cover HD this month. Most plans haven't added it yet. Your 2.4 mg coverage doesn't automatically extend to HD — plans treat HD as a separate formulary decision.
The Wegovy Savings Offer terms do include HD in the commercial-coverage branch at as little as $25/month with a maximum savings of $100/month. Once your specific plan adds HD to its formulary, the Savings Offer pathway opens.
Government insurance remains excluded. Medicare, Medicaid, TRICARE, and VA beneficiaries are not eligible for the Wegovy Savings Offer regardless of formulary status.
Medicare Part D does cover Wegovy for the cardiovascular risk-reduction indication in patients with established heart disease. That's not an obesity coverage pathway, and HD formulary inclusion under Medicare Part D is determined plan by plan.

The practical insurance plan for April 2026:

  1. Plan to pay cash for HD now. That makes the 12-month WW Medication Commitment at $249/month the strongest cost-reduction option available today.
  2. If you have commercial insurance, use it for your 2.4 mg coverage. Ro's free GLP-1 Insurance Coverage Checker and insurance concierge are the strongest tools we verified for running a standard-dose Wegovy prior authorization.
  3. Re-check HD coverage every few months. Your plan's formulary may add HD at its next update window. When it does, the Wegovy Savings Offer kicks in.
  4. Don't pay for a "premium insurance-navigation" platform specifically because you expect it to unlock HD this month. Insurance concierge platforms add real value for standard Wegovy and future HD coverage — they cannot create coverage that doesn't exist yet.

Ro's Insurance Coverage Checker runs your plan in about 2 minutes. No payment, no commitment. Useful now for 2.4 mg; ready for HD when your plan adds it.

What to expect on Wegovy HD (including the new dysesthesia signal)

Most people stepping up to Wegovy HD will experience more gastrointestinal side effects than they did on 2.4 mg — about 71% of STEP UP trial participants on 7.2 mg reported nausea, vomiting, diarrhea, constipation, or abdominal pain, versus 61% on 2.4 mg. The genuinely new signal at 7.2 mg is dysesthesia — altered skin sensations like tingling, burning, or heightened sensitivity — which about 22% of trial participants on HD reported, compared to 6% on 2.4 mg and 0.3% on placebo.

What dysesthesia feels like, in plain language:

Patients describe it as tingling, pins-and-needles, a burning feeling, or heightened sensitivity on skin that shouldn't be particularly sensitive. It can show up on the scalp, face, arms, or legs. It typically appears within the first few weeks of being on the higher dose and often resolves on its own. If it doesn't resolve, or if it's severe, your prescriber may pause the step-up and keep you on 2.4 mg longer.

The serious warnings (boxed warning — same as standard Wegovy):

  • Thyroid C-cell tumors (Boxed Warning): Do not use if you or a family member have ever had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). Tell your prescriber about any lump or swelling in the neck, hoarseness, or trouble swallowing.
  • Pancreatitis: Sudden, severe abdominal pain that doesn't resolve is a call-911 signal.
  • Gallbladder problems: Rapid weight loss increases gallstone risk; be alert for upper-right abdominal pain.
  • Hypoglycemia: If you're on insulin or a sulfonylurea for diabetes, your prescriber may adjust those medications.
  • Aspiration risk: Tell any surgeon, anesthesiologist, or dentist about your medication before any procedure involving sedation.
  • Pregnancy: Stop using at least 2 months before planned pregnancy, and stop immediately if you become pregnant.

When to message your telehealth provider:

Any persistent GI symptom past week 2, any dysesthesia that doesn't resolve within 4 weeks, any signs of dehydration, any unusual fatigue, any rapid heart rate, any new skin rash.

When to call 911 or go to the ER:

Severe abdominal pain that won't stop, signs of a severe allergic reaction (facial swelling, difficulty breathing, severe rash), symptoms of severe hypoglycemia (confusion, loss of consciousness).

This is general information, not medical advice — always defer to your prescribing clinician on your specific situation.

Wegovy HD vs. Wegovy pill: which should you pick?

Wegovy HD (7.2 mg weekly injection) produces more average weight loss than the Wegovy pill (25 mg daily tablet) in clinical trials — roughly 20.7% vs. 14–17% over comparable windows — but the pill is cheaper ($149–$299/month), needle-free, and available without the "must have been on 2.4 mg first" gate.

FactorWegovy HD (7.2 mg injection)Wegovy pill (oral semaglutide)
AdministrationOnce-weekly injectionOnce-daily pill, empty stomach
Top-dose efficacy (trial avg.)~20.7% body weight loss over 72 weeks~14–17% body weight loss over 64 weeks
Starting eligibilityMust be on 2.4 mg injection for 4+ weeksNone — you can start on the pill
Top-dose price (cash-pay)$399/month$299/month (9 mg or 25 mg dose)
HSA/FSA eligibleYesYes
Cardiovascular risk reduction indicationYesYes
Needle-freeNoYes
Daily routine requiredNo (once weekly)Yes — empty stomach, wait 30 min before food/drink/meds

Pick HD if:

You've already plateaued on the 2.4 mg injection, you tolerate semaglutide well, you want the highest efficacy available, and you're fine with the weekly injection routine you already have.

Pick the pill if:

You haven't started Wegovy yet and don't want to start with needles, you want the lowest cost path, or you've had trouble tolerating the injection.

Don't think of it as HD-vs-pill for most people — think of it as a progression. Many patients start on the pill, titrate up, and then either stay there or switch to injection and eventually step up to HD. The real decision is "where am I right now, and what's the next step?"

See our Wegovy HD vs Wegovy pill deep dive

Wegovy HD vs. Zepbound: when HD is right and when it isn't

Wegovy HD (semaglutide 7.2 mg) and Zepbound (tirzepatide, up to 15 mg) are the two most effective FDA-approved weight-loss injections on the market today. Zepbound has produced comparable top-dose weight loss in its own trials (~20.9% at 15 mg over 72 weeks). Wegovy HD carries a cardiovascular risk-reduction indication that Zepbound doesn't. Zepbound carries an obstructive sleep apnea indication that Wegovy doesn't.

FactorWegovy HDZepbound
Active ingredientSemaglutide (GLP-1)Tirzepatide (GLP-1 + GIP)
Top-dose efficacy (trial avg.)~20.7% body weight loss, 72 weeks~20.9% body weight loss, 72 weeks (15 mg)
Dysesthesia signal at top dose~22%Not reported at comparable rate
Cardiovascular risk reduction indicationYes (in adults with heart disease + obesity)No
Sleep apnea indicationNoYes
Eligibility gate to reach top doseMust tolerate 2.4 mg Wegovy ≥4 weeksMust titrate from 2.5 mg through intermediate doses
Available through telehealthYesYes (Ro, LifeMD, Sesame, Hims/Hers, and others)

Pick Wegovy HD if:

  • • Already plateaued on Wegovy 2.4 mg and tolerating it
  • • Have established cardiovascular disease and want the heart-risk-reduction claim
  • • Tried tirzepatide and it didn't work for you

Pick Zepbound if:

  • • Haven't committed to semaglutide and GI tolerance matters to you
  • • Have diagnosed obstructive sleep apnea
  • • Insurance covers Zepbound but not Wegovy (or vice versa)
  • • Want the dual GLP-1 + GIP mechanism
The honest thing no one says: for many people with no contraindications either way, the "best" medication is the one your insurance will cover, the one you tolerate, and the one you'll actually stay on. Efficacy in a clinical trial isn't the same as efficacy in your life.

How to avoid fake "Wegovy HD" online

Authentic Wegovy HD comes from Novo Nordisk through licensed U.S. pharmacies — NovoCare Pharmacy, CenterWell Pharmacy, and licensed retail pharmacies. If a website offers "Wegovy HD" at prices dramatically below $399/month cash-pay, ships from outside the U.S., doesn't require a prescription, sells multi-dose vials, or markets compounded 7.2 mg semaglutide as equivalent to HD — that is not Wegovy HD. There is no generic Wegovy HD in April 2026.

What to check before you commit to any provider:

1.Does the provider explicitly list Wegovy HD or the 7.2 mg dose? The providers on this page with explicit HD listings are WeightWatchers Med+, Hims, Hers, NovoCare, and GoodRx. Ro, LifeMD, and Sesame route through NovoCare or direct Novo partnerships — confirm HD availability during your visit.
2.What pharmacy does the medication ship from? Legitimate routes name NovoCare Pharmacy, CenterWell Pharmacy, or a named U.S. licensed pharmacy. If the answer is vague, that's a red flag.
3.Is the medication cost $399/month at self-pay, or very close to it? Significant deviation below that price, unless explained by a specific published promotion (like WW's 12-month Medication Commitment) or insurance coverage, is worth questioning.
4.Do they require a prescription? Yes, always. Anyone offering Wegovy HD without a prescription is not offering Wegovy HD.
5.Are they selling compounded semaglutide at 7.2 mg and implying it's equivalent to Wegovy HD? That's a problem. The FDA has issued explicit warnings about telehealth companies blurring this line.
6.Can you find their pharmacy license and physical address? U.S.-licensed pharmacies are publicly searchable.

Frequently asked questions

No. The FDA label requires you to have tolerated the 2.4 mg Wegovy dose for at least 4 weeks before HD is a clinical option. No legitimate telehealth platform can override this — if a provider tells you otherwise, that is a serious red flag.

Yes. As of April 2026, Wegovy HD is accessible through WeightWatchers Med+, Hims, Hers, NovoCare Pharmacy, GoodRx Care Direct, Ro Body (via NovoCare integration), LifeMD (via Novo partnership), and Sesame Care (via NovoCare routing). The first five publish HD-specific pricing on their main consumer pages; the others confirm HD availability at the eligibility visit. We verified each on April 22, 2026.

Medication is $399/month cash-pay through NovoCare Pharmacy — which means most telehealth platforms charge $399/month for HD as well, because they route through NovoCare. Add the platform's membership fee for the all-in cost: as low as about $314.83/month effective (WeightWatchers with 12-month commitment) to roughly $538/month (Hims, Hers, or Ro on monthly billing).

Not currently, for most patients. Novo Nordisk's own live coverage tool states no insurance coverage is currently available for the 7.2 mg dose. Most commercial plans haven't added HD to their formularies yet. Plan to pay cash for HD in April 2026, and re-check coverage every few months as formularies update.

At time of verification (April 22, 2026), WeightWatchers Med+, Hims, Hers, NovoCare Pharmacy, and GoodRx Care Direct explicitly reference the 7.2 mg dose on their consumer pages. Ro Body, LifeMD, and Sesame Care route Wegovy through NovoCare or direct Novo partnerships and can provide HD to eligible patients — confirm HD-specific pricing at your first visit.

Yes, but you won't jump straight to HD. Most clinicians will want to transition you to Wegovy 2.4 mg first, confirm you tolerate semaglutide, and then step you up to HD after the 4-week period. Plan for 8–12 weeks for a full transition.

Yes — it's a prescribed FDA-approved medication, which makes it HSA and FSA eligible. Hims and Hers specifically separate medication cost from membership cost so the medication portion is clean for HSA/FSA reimbursement. Paying directly with an HSA or FSA card may require extra verification depending on the provider; most people pay with a credit card and submit receipts.

Your prescriber can step you back down to 2.4 mg. You don't lose access to Wegovy — you just maintain at the previous dose. Dysesthesia and severe GI side effects are the two most common reasons patients step back.

On trial averages, yes — Wegovy HD produced roughly 20.7% average body weight loss in STEP UP vs. 14–17% for the pill in its trials. But the pill has its own advantages (no needle, lower cost, no 4-week prerequisite). Don't think of HD as a "stronger pill" — think of it as the next step after 2.4 mg injection.

Novo Nordisk has said HD will be added to the multi-month subscription program at a later date but has not announced a specific timeline. The subscription program currently drops standard Wegovy pen doses (0.25–2.4 mg) to as low as $249/month on a 12-month plan. If the same pricing eventually applies to HD, that would be a meaningful savings.

No. Semaglutide is under patent protection in the U.S. and there is no FDA-approved generic Wegovy HD. Anyone advertising "generic Wegovy HD" or selling compounded 7.2 mg semaglutide as equivalent is either confused or deliberately misleading.

Wegovy HD is an FDA-approved brand-name medication manufactured by Novo Nordisk, tested in the STEP UP trial, and dispensed through licensed U.S. pharmacies. Compounded semaglutide dosed at 7.2 mg is a different product — not FDA-approved, not Wegovy, not guaranteed to contain the same active ingredient in the same formulation. The FDA has warned telehealth companies specifically about blurring this distinction.

Still not sure which Wegovy HD route is right for you?

If you're still on the fence — maybe you're not yet sure you qualify for HD, maybe you're weighing HD against the pill, or maybe you're comparing HD to Zepbound — use the provider that best matches your top priority from the list above. The quiz is built on the same verification data as this page.

About this guide

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We build these guides by pulling pricing and policy information directly from each provider's published pages, cross-referencing manufacturer data from Novo Nordisk and Eli Lilly, and checking FDA sources for medication status. We earn affiliate commissions from some of the platforms we recommend — this doesn't change what we rank or how we rank it. Providers don't pay for placement, and we publish honest trade-offs and damaging admissions even for platforms we link to.

Last verified:

Next scheduled verification: May 22, 2026

Primary sources checked (click to expand)

• FDA press release on Wegovy HD approval (March 19, 2026)

• Wegovy prescribing information (updated 2026)

• NovoCare coverage checker (novocare.com/patient/medicines/wegovy/check-coverage.html)

• NovoCare Pharmacy pricing (novocare.com/pharmacy.html)

• Wegovy self-pay pricing (wegovy.com/obesity/what-to-pay-for-wegovy.html)

• Ro Body pricing (ro.co/weight-loss/pricing) and Wegovy product page (ro.co/weight-loss/wegovy)

• LifeMD Wegovy pages (lifemd.com/novocare/wegovy) and membership page (lifemd.com/membership)

• WeightWatchers Med+ Wegovy page (weightwatchers.com/us/weight-loss-medication/wegovy)

• Hims Wegovy pen page (hims.com/weight-loss/wegovy-pen)

• Hers Wegovy pen page (forhers.com/weight-loss/wegovy-pen)

• Sesame Care Wegovy page (sesamecare.com/medication/wegovy)

• GoodRx Care Wegovy HD announcement (investors.goodrx.com)

• Walgreens Virtual Care Wegovy page (walgreens.com/topic/virtual-healthcare/weight-loss/wegovy.jsp)

• Novo Nordisk press releases dated March 31, 2026 and April 7, 2026

• FDA press release on telehealth marketing of compounded GLP-1s

• STEP UP trial published in The Lancet; HCPLive coverage; Endocrinology Advisor; WebMD drug update on Wegovy HD

This page is for informational purposes and is not medical advice. Talk to a licensed healthcare provider about whether Wegovy HD is right for you. Wegovy® is a registered trademark of Novo Nordisk A/S. Zepbound® is a registered trademark of Eli Lilly and Company. Weight Loss Provider Guide has no affiliation with Novo Nordisk or Eli Lilly and is not sponsored or endorsed by either manufacturer.